How May GIP Enhance the Therapeutic Efficacy of GLP-1?

Samms, RJ; Goghlan, MP; Sloop, KW

Sloop, KW (corresponding author), Eli Lilly & Co, Lilly Res Labs, Diabet & Complicat, Indianapolis, IN 46285 USA.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020; 31 (6): 410

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists improve glucose homeostasis, reduce body weight, and over time benefit cardiovascular health in type......

Full Text Link